Revvity

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Revvity and other ETFs, options, and stocks.

About RVTY

Revvity, Inc. provides health science solutions, technologies, expertise, and services that deliver complete workflows from discovery to development, and diagnosis to cure. It focuses on translational multi-omics technologies, biomarker identification, imaging, prediction, screening, detection and diagnosis, and informatics. 

CEO
Prahlad Ramadhar Singh
CEOPrahlad Ramadhar Singh
Employees
11,000
Employees11,000
Headquarters
Waltham, Massachusetts
HeadquartersWaltham, Massachusetts
Founded
1937
Founded1937
Employees
11,000
Employees11,000

RVTY Key Statistics

Market cap
11.61B
Market cap11.61B
Price-Earnings ratio
47.54
Price-Earnings ratio47.54
Dividend yield
0.28%
Dividend yield0.28%
Average volume
1.63M
Average volume1.63M
High today
$106.00
High today$106.00
Low today
$101.36
Low today$101.36
Open price
$101.80
Open price$101.80
Volume
1.24M
Volume1.24M
52 Week high
$118.30
52 Week high$118.30
52 Week low
$81.22
52 Week low$81.22

Stock Snapshot

The current Revvity(RVTY) stock price is $104.33, with a market capitalization of 11.61B. The stock trades at a price-to-earnings (P/E) ratio of 47.54 and offers a dividend yield of 27.9%.

On 2026-06-10, Revvity(RVTY) stock traded between a low of $101.36 and a high of $106.00. Shares are currently priced at $104.33, which is +2.9% above the low and -1.6% below the high.

Revvity(RVTY) shares are trading with a volume of 1.24M, against a daily average of 1.63M.

During the past year, Revvity(RVTY) stock moved between $81.22 at its lowest and $118.30 at its peak.

During the past year, Revvity(RVTY) stock moved between $81.22 at its lowest and $118.30 at its peak.

RVTY News

MarketWatch 1d
Revvity Inc. stock outperforms competitors on strong trading day - MarketWatch

...

Revvity Inc. stock outperforms competitors on strong trading day - MarketWatch
Simply Wall St 2d
How Investors May Respond To Revvity Divesting Its China Immunodiagnostics Business

In early June 2026, Revvity announced plans to divest its immunodiagnostics business in China, which accounted for about 6% of revenue, after reporting first-qu...

How Investors May Respond To Revvity Divesting Its China Immunodiagnostics Business

Analyst ratings

56%

of 18 ratings
Buy
44.4%
Hold
55.6%
Sell
0%

People also own

Based on the portfolios of people who own RVTY. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.